Nagayama K - Search Results

1

Characteristics of hepatitis C viral genome associated with disease progression.

Nagayama K, Kurosaki M, Enomoto N, Miyasaka Y, Marumo F, Sato C. Nagayama K, et al. Hepatology. 2000 Mar;31(3):745-50. doi: 10.1002/hep.510310327. Hepatology. 2000. PMID: 10706567

2

Time-related changes in full-length hepatitis C virus sequences and hepatitis activity.

Nagayama K, Kurosaki M, Enomoto N, Maekawa SY, Miyasaka Y, Tazawa J, Izumi N, Marumo F, Sato C. Nagayama K, et al. Virology. 1999 Oct 10;263(1):244-53. doi: 10.1006/viro.1999.9924. Virology. 1999. PMID: 10544098 Free article.

3

Genetic changes in the interferon sensitivity determining region of hepatitis C virus during the natural course of chronic hepatitis C.

Maekawa S, Enomoto N, Kurosaki M, Nagayama K, Marumo F, Sato C. Maekawa S, et al. Among authors: nagayama k. J Med Virol. 2000 Jul;61(3):303-10. doi: 10.1002/1096-9071(200007)61:3<303::aid-jmv4>3.0.co;2-f. J Med Virol. 2000. PMID: 10861637

4

Intrahepatic mRNA expression of interferon-inducible antiviral genes in liver diseases: dsRNA-dependent protein kinase overexpression and RNase L inhibitor suppression in chronic hepatitis C.

Yu SH, Nagayama K, Enomoto N, Izumi N, Marumo F, Sato C. Yu SH, et al. Among authors: nagayama k. Hepatology. 2000 Nov;32(5):1089-95. doi: 10.1053/jhep.2000.19287. Hepatology. 2000. PMID: 11050060

5

CD81 nucleotide mutation in hepatocellular carcinoma and lack of CD81 polymorphism in patients at stages of hepatitis C virus infection.

Itakura J, Nagayama K, Enomoto N, Sakamoto N, Tazawa J, Izumi N, Marumo F, Sato C. Itakura J, et al. Among authors: nagayama k. J Med Virol. 2001 Jan;63(1):22-8. J Med Virol. 2001. PMID: 11130883

6

Sequences in the NS5A protein of hepatitis C virus and the serum alanine aminotransferase response to interferon therapy in Japanese patients.

Nagayama K, Enomoto N, Izumi N, Kurosaki M, Miyasaka Y, Watanabe H, Itakura J, Chen CH, Tazawa J, Hoshino Y, Ikeda T, Marumo F, Sato C. Nagayama K, et al. Gut. 2001 Jun;48(6):830-5. doi: 10.1136/gut.48.6.830. Gut. 2001. PMID: 11358904 Free PMC article.

7

Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization.

Miyasaka Y, Enomoto N, Nagayama K, Izumi N, Marumo F, Watanabe M, Sato C. Miyasaka Y, et al. Among authors: nagayama k. Br J Cancer. 2001 Jul 20;85(2):228-34. doi: 10.1054/bjoc.2001.1901. Br J Cancer. 2001. PMID: 11461082 Free PMC article.

8

Characteristic sequence changes of hepatitis C virus genotype 2b associated with sustained biochemical response to IFN therapy.

Tanabe Y, Nagayama K, Enomoto N, Izumi N, Tazawa J, Kurosaki M, Sakamoto N, Sato C, Watanabe M. Tanabe Y, et al. Among authors: nagayama k. J Viral Hepat. 2005 May;12(3):251-61. doi: 10.1111/j.1365-2893.2005.00511.x. J Viral Hepat. 2005. PMID: 15850465

9

[A case of autoimmune hepatitis associated with anti-phospholipid antibody syndrome].

Nagayama K, Izumi N, Watanabe H, Saito K, Miyasaka Y, Noguchi O, Hoshino Y, Uchihara M, Miyake S, Sawabe M, Enomoto N, Tanaka Y, Marumo F, Sato C. Nagayama K, et al. Nihon Shokakibyo Gakkai Zasshi. 1997 Oct;94(10):695-9. Nihon Shokakibyo Gakkai Zasshi. 1997. PMID: 9391333 Japanese. No abstract available.

10

Number and position of mutations in the interferon (IFN) sensitivity-determining region of the gene for nonstructural protein 5A correlate with IFN efficacy in hepatitis C virus genotype 1b infection.

Watanabe H, Enomoto N, Nagayama K, Izumi N, Marumo F, Sato C, Watanabe M. Watanabe H, et al. Among authors: nagayama k. J Infect Dis. 2001 Apr 15;183(8):1195-203. doi: 10.1086/319674. Epub 2001 Mar 14. J Infect Dis. 2001. PMID: 11262201

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters